Bionano Genomics Inc (BNGO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BNGO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Bionano Genomics Inc Stock (BNGO) Company Profile

Bionano Genomics Inc

Healthcare (1155)

(858) 888-7600

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

@bionanogenomics

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BNGO's Discussions on Twitter

Vergleichen Sie BNGO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BNGO Bionano Genomics Inc	4.05	13.44M	36.12M	-232.49M	-126.87M	-17.78
ISRG Intuitive Surgical Inc	476.57	175.60B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	199.00	57.39B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	93.27	45.22B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	214.19	31.43B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	79.60	15.88B	3.90B	392.30M	288.10M	1.95

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-15	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2024-09-10	Herabstufung	BTIG Research	Buy → Neutral
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-12-12	Fortgesetzt	BTIG Research	Buy
2022-07-18	Fortgesetzt	Oppenheimer	Outperform
2021-06-16	Eingeleitet	BTIG Research	Buy
2020-09-24	Eingeleitet	Ladenburg Thalmann	Buy
2020-04-08	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten

Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc Stock (BNGO) Company Profile

Vergleichen Sie BNGO mit anderen Aktien

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten

Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - ADVFN

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - ADVFN

Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus

Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus

Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus

Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus

Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (LSE:0A4K) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com

Richardson Electronics Q3 2025 Earnings Call Transcript - MarketBeat

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - The Manila Times

Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan

(BNGO) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st

Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript - Insider Monkey

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... By GuruFocus - Investing.com Canada

Bionano Genomics Reports 2024 Financial Results - TipRanks

Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization - MSN

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Yahoo Finance

Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa

Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com

Bionano Genomics, Inc. SEC 10-K Report - TradingView

Bionano Genomics Reports Q4 and Full-Year 2024 Results - TradingView

Stock Market Correction: 2 Warren Buffett Stocks to Buy Hand Over Fist - The Globe and Mail

Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView

SoFi Stock Is Down 23% YTD. Should You Buy the Dip or Stay Away? - The Globe and Mail

What's Next: Bionano Genomics's Earnings Preview - Benzinga

Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail

Hakluyt appoints Ronald Sugar to its International Advisory Board - The Globe and Mail

BNGO stock touches 52-week low at $3.15 amid market challenges By Investing.com - Investing.com South Africa

BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com Australia

LYFT Stock Gains as Activist Investor Engine Capital Builds Stake - The Globe and Mail

Bionano Genomics and Greenwood Genetic Center Publish Study Using Optical Genome Mapping to Advance Understanding of Neural Tube Defects - Nasdaq

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - The Manila Times

Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - StockTitan

3 Services Stocks Skating on Thin Ice - The Globe and Mail

BNGO stock touches 52-week low at $3.28 amid market challenges - Investing.com Australia

BNGO stock touches 52-week low at $3.28 amid market challenges By Investing.com - Investing.com South Africa

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - The Manila Times

Leading Experts Validate Bionano's Genome Mapping Technology at Major Medical Conference - StockTitan

(BNGO) Technical Data - Stock Traders Daily

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - The Manila Times

Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie BNGO